Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Gauthami Jalagadugula"'
Autor:
Gauthami Jalagadugula, Lawrence E. Goldfinger, Guangfen Mao, Michele P. Lambert, A. Koneti Rao
Publikováno v:
Blood Advances, Vol 2, Iss 7, Pp 797-806 (2018)
Abstract: Patients with RUNX1 haplodeficiency have thrombocytopenia, platelet dysfunction, and deficiencies of α-granules and dense granules. Platelet expression profiling of a patient with a heterozygous RUNX1 mutation (c.969-323G>T) revealed decre
Externí odkaz:
https://doaj.org/article/0d97a35f27784031a8aa180f04379b2d
Autor:
Gauthami Jalagadugula, Guangfen Mao, Lawrence E. Goldfinger, Jeremy Wurtzel, Fabiola Del Carpio-Cano, Michele P. Lambert, Brian Estevez, Deborah L. French, Mortimer Poncz, A. Koneti Rao
Publikováno v:
Blood Advances. 6:5100-5112
Transcription factor RUNX1 is a master regulator of hematopoiesis and megakaryopoiesis. RUNX1 haplodeficiency (RHD) is associated with thrombocytopenia and platelet granule deficiencies and dysfunction. Platelet profiling of our study patient with RH
Publikováno v:
J Neuroimmune Pharmacol
Virus-induced diseases or neurological complications are huge socio-economic burden to human health globally. The complexity of viral-mediated CNS pathology is exacerbated by reemergence of new pathogenic neurotropic viruses of high public relevance.
Autor:
Deepak Voora, Emily Harris, Gauthami Jalagadugula, Rachel A. Myers, Thomas L. Ortel, A. Koneti Rao, Geoffrey S. Ginsburg
Publikováno v:
EBioMedicine, Vol 11, Iss C, Pp 157-164 (2016)
EBioMedicine
EBioMedicine
Aspirin prevents cardiovascular disease and colon cancer; however aspirin's inhibition of platelet COX-1 only partially explains its diverse effects. We previously identified an aspirin response signature (ARS) in blood consisting of 62 co-expressed
Autor:
A. Koneti Rao, Michele P. Lambert, Guangfen Mao, Lawrence E. Goldfinger, Gauthami Jalagadugula
Patients with RUNX1 haplodeficiency have thrombocytopenia, platelet dysfunction, and deficiencies of α-granules and dense granules. Platelet expression profiling of a patient with a heterozygous RUNX1 mutation (c.969-323G>T) revealed decreased RAB1B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2534edb228f20aecb54cc984be444e42
https://europepmc.org/articles/PMC5894258/
https://europepmc.org/articles/PMC5894258/
Autor:
A. Koneti Rao, Guenther Boden, Gauthami Jalagadugula, Peter Cheung, Andrew A. Wiles, Robert J. Freishtat, Anamika Singh, Guangfen Mao
Publikováno v:
Thrombosis Research. 134:704-710
Introduction Diabetes mellitus (DM) is a prothrombotic and proinflammatory state. Hyperglycemia (HG) is encountered even in patients without DM. We have shown that combined HG and hyperinsulinemia (HI) in healthy non-diabetic subjects increased circu
Autor:
Robert J. Freishtat, D C Fan, Gauthami Jalagadugula, AK Rao, Guangfen Mao, Michele P. Lambert, Lawrence E. Goldfinger
Publikováno v:
Journal of thrombosis and haemostasis : JTH. 15(4)
Essentials Platelet dense granule (DG) deficiency is a major abnormality in RUNX1 haplodeficiency patients. The molecular mechanisms leading to the platelet DG deficiency are unknown. Platelet expression of PLDN (BLOC1S6, pallidin), involved in DG bi
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 31:921-927
Objective— Mutations in the hematopoietic transcription factor RUNX1 cause thrombocytopenia and impaired platelet function. In a patient with a heterozygous mutation in RUNX1, we have described decreased platelet pleckstrin phosphorylation and prot
Publikováno v:
Journal of Thrombosis and Haemostasis. 9:383-391
Summary. Background: Platelet factor 4 (PF4) is an abundant protein stored in platelet α-granules. Several patients have been described with platelet PF4 deficiency, including the gray platelet syndrome, characterized by a deficiency of α-granule p
Autor:
Gurpreet Kaur, Gauthami Jalagadugula, Danny N. Dhanasekaran, Lawrence E. Goldfinger, A. Koneti Rao, Guangfen Mao
Publikováno v:
Blood. 116:6037-6045
Mutations in transcription factor RUNX1 are associated with familial platelet disorder, thrombocytopenia, and predisposition to leukemia. We have described a patient with thrombocytopenia and impaired agonist-induced platelet aggregation, secretion,